{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:25:00Z","timestamp":1790115900539,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-023-02840-y","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T06:15:52Z","timestamp":1680502552000},"page":"1397-1404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Trends in diagnosis of cardiac transthyretin amyloidosis: 3-year analysis of scintigraphic studies: Prevalence of myocardial uptake and its predictor factors"],"prefix":"10.1007","volume":"39","author":[{"given":"Mar\u00eda del Carmen","family":"Navarro-Saez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Feijoo-Mass\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zully del Carmen","family":"Bravo Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Carles","family":"Oliva Morera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Mar\u00eda","family":"Balado Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Palau-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Guillamon Toran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Comet Monte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreu","family":"Fern\u00e1ndez-Codina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,1]]},"reference":[{"key":"2840_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.recesp.2011.05.003","author":"P Garc\u00eda-Pav\u00eda","year":"2011","unstructured":"Garc\u00eda-Pav\u00eda P, Tom\u00e9-Esteban MT, Rapezzi C (2011) Amiloidosis Tambi\u00e9n una enfermedad del coraz\u00f3n [Amyloidosis Also a heart disease]. Rev Esp Cardiol. https:\/\/doi.org\/10.1016\/j.recesp.2011.05.003","journal-title":"Rev Esp Cardiol"},{"issue":"2","key":"2840_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","volume":"20","author":"C Rapezzi","year":"2015","unstructured":"Rapezzi C, Lorenzini M, Longhi S, Milandri A, Gagliardi C, Bartolomei I, Salvi F, Maurer MS (2015) Cardiac amyloidosis: the great pretender. Heart Fail Rev 20(2):117\u2013124. https:\/\/doi.org\/10.1007\/s10741-015-9480-0","journal-title":"Heart Fail Rev"},{"issue":"16","key":"2840_CR3","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","volume":"42","author":"P Garcia-Pavia","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Linhart A (2021) Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 42(16):1554\u20131568. https:\/\/doi.org\/10.1093\/eurheartj\/ehab072","journal-title":"Eur Heart J"},{"issue":"9","key":"2840_CR4","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jacep.2020.04.019","volume":"6","author":"E Donnellan","year":"2020","unstructured":"Donnellan E, Wazni OM, Hanna M, Elshazly MB, Puri R, Saliba W, Kanj M, Vakamudi S, Patel DR, Baranowski B, Cantillon D, Dresing T, Jaber WA (2020) Atrial fibrillation in transthyretin cardiac amyloidosis: predictors, prevalence, and efficacy of rhythm control strategies. JACC Clin Electrophysiol 6(9):1118\u20131127. https:\/\/doi.org\/10.1016\/j.jacep.2020.04.019","journal-title":"JACC Clin Electrophysiol"},{"key":"2840_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Hawkins PN (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.021612","journal-title":"Circulation"},{"issue":"6","key":"2840_CR6","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","volume":"46","author":"E Perugini","year":"2005","unstructured":"Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L, Leone O, Farsad M, Ciliberti P, Bacchi-Reggiani L, Fallani F, Branzi A, Rapezzi C (2005) Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 46(6):1076\u20131084. https:\/\/doi.org\/10.1016\/j.jacc.2005.05.073","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"2840_CR7","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, ESC Scientific Document Group (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"issue":"4","key":"2840_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0002-9343(96)00229-X","volume":"101","author":"RA Kyle","year":"1996","unstructured":"Kyle RA, Spittell PC, Gertz MA, Li CY, Edwards WD, Olson LJ, Thibodeau SN (1996) The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 101(4):395\u2013400. https:\/\/doi.org\/10.1016\/S0002-9343(96)00229-X","journal-title":"Am J Med"},{"issue":"12","key":"2840_CR9","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1001\/archinte.165.12.1425","volume":"165","author":"B Ng","year":"2005","unstructured":"Ng B, Connors LH, Davidoff R, Skinner M, Falk RH (2005) Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 165(12):1425\u20131429. https:\/\/doi.org\/10.1001\/archinte.165.12.1425","journal-title":"Arch Intern Med"},{"key":"2840_CR10","doi-asserted-by":"publisher","first-page":"10787","DOI":"10.1038\/ncomms10787","volume":"7","author":"R Sant'Anna","year":"2016","unstructured":"Sant\u2019Anna R, Gallego P, Robinson LZ, Pereira-Henriques A, Ferreira N, Pinheiro F, Esperante S, Pallares I, Huertas O, Almeida MR, Reixach N, Insa R, Velazquez-Campoy A, Reverter D, Reig N, Ventura S (2016) Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity. Nat Commun 7:10787. https:\/\/doi.org\/10.1038\/ncomms10787","journal-title":"Nat Commun"},{"key":"2840_CR11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208760","author":"T Coelho","year":"2013","unstructured":"Coelho T, Adams D, Silva A, Lozeron P, Hawkins PN, Mant T, Perez J, Chiesa J, Warrington S, Tranter E, Munisamy M, Falzone R, Harrop J, Cehelsky J, Bettencourt BR, Geissler M, Butler JS, Sehgal A, Meyers RE, Chen Q, Suhr OB (2013) Safety and efficacy of RNAi therapy for transthyretin amyloidosis. New Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa1208760","journal-title":"New Engl J Med"},{"key":"2840_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13023-015-0326-6","volume":"10","author":"OB Suhr","year":"2015","unstructured":"Suhr OB, Coelho T, Buades J, Pouget J, Conceicao I, Berk J, Schmidt H, Waddington-Cruz M, Campistol JM, Bettencourt BR, Vaishnaw A, Gollob J, Adams D (2015) Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study. Orphanet J Rare Dis 10:109. https:\/\/doi.org\/10.1186\/s13023-015-0326-6","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"2840_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, ATTR-ACT Study Investigators (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. New Engl J Med 379(11):1007\u20131016. https:\/\/doi.org\/10.1056\/NEJMoa1805689","journal-title":"New Engl J Med"},{"issue":"5","key":"2840_CR14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/hrt.27.5.711","volume":"27","author":"A Pomerance","year":"1965","unstructured":"Pomerance A (1965) Senile cardiac amyloidosis. Br Heart J 27(5):711\u2013718. https:\/\/doi.org\/10.1136\/hrt.27.5.711","journal-title":"Br Heart J"},{"key":"2840_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)90443-6","author":"GG Cornwell 3rd","year":"1983","unstructured":"Cornwell GG 3rd, Murdoch WL, Kyle RA, Westermark P, Pitk\u00e4nen P (1983) Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med. https:\/\/doi.org\/10.1016\/0002-9343(83)90443-6","journal-title":"Am J Med"},{"issue":"3","key":"2840_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/07853890701842988","volume":"40","author":"M Tanskanen","year":"2008","unstructured":"Tanskanen M, Peuralinna T, Polvikoski T, Notkola IL, Sulkava R, Hardy J, Singleton A, Kiuru-Enari S, Paetau A, Tienari PJ, Myllykangas L (2008) Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med 40(3):232\u2013239. https:\/\/doi.org\/10.1080\/07853890701842988","journal-title":"Ann Med"},{"issue":"38","key":"2840_CR17","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","volume":"36","author":"E Gonz\u00e1lez-L\u00f3pez","year":"2015","unstructured":"Gonz\u00e1lez-L\u00f3pez E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, Bornstein B, Salas C, Lara-Pezzi E, Alonso-Pulpon L, Garcia-Pavia P (2015) Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 36(38):2585\u20132594. https:\/\/doi.org\/10.1093\/eurheartj\/ehv338","journal-title":"Eur Heart J"},{"key":"2840_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/HCI.0000000000000029","author":"S Dorbala","year":"2021","unstructured":"Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Bourque JM (2021) ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging circulation. Cardiovasc Imag. https:\/\/doi.org\/10.1161\/HCI.0000000000000029","journal-title":"Cardiovasc Imag"},{"key":"2840_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-med-052918-020140","volume":"71","author":"J Rubin","year":"2020","unstructured":"Rubin J, Maurer MS (2020) Cardiac amyloidosis: overlooked, underappreciated, and treatable. Annu Rev Med 71:203\u2013219. https:\/\/doi.org\/10.1146\/annurev-med-052918-020140","journal-title":"Annu Rev Med"},{"issue":"38","key":"2840_CR20","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","volume":"38","author":"A Casta\u00f1o","year":"2017","unstructured":"Casta\u00f1o A, Narotsky DL, Hamid N, Khalique OK, Morgenstern R, DeLuca A, Rubin J, Chiuzan C, Nazif T, Vahl T, George I, Kodali S, Leon MB, Hahn R, Bokhari S, Maurer MS (2017) Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 38(38):2879\u20132887. https:\/\/doi.org\/10.1093\/eurheartj\/ehx350","journal-title":"Eur Heart J"},{"key":"2840_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ijcard.2018.06.006","volume":"270","author":"L Mohamed-Salem","year":"2018","unstructured":"Mohamed-Salem L, Santos-Mateo JJ, Sanchez-Serna J, Hern\u00e1ndez-Vicente \u00c1, Reyes-Marle R, Castell\u00f3n S\u00e1nchez MI, Claver-Valderas MA, Gonzalez-Vioque E, Haro-Del Moral FJ, Garc\u00eda-Pav\u00eda P, Pascual-Figal DA (2018) Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population. Int J Cardiol 270:192\u2013196. https:\/\/doi.org\/10.1016\/j.ijcard.2018.06.006","journal-title":"Int J Cardiol"},{"issue":"3","key":"2840_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1536\/ihj.18-345","volume":"60","author":"HM Kim","year":"2019","unstructured":"Kim HM, Sohn DW, Paeng JC (2019) Prevalence of Positive 99 mTc-DPD Scintigraphy as an Indicator of the Prevalence of Wild-type Transthyretin Amyloidosis in the Elderly. Int Heart J 60(3):643\u2013647. https:\/\/doi.org\/10.1536\/ihj.18-345","journal-title":"Int Heart J"},{"issue":"5","key":"2840_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jcmg.2014.03.004","volume":"7","author":"S Longhi","year":"2014","unstructured":"Longhi S, Guidalotti PL, Quarta CC, Gagliardi C, Milandri A, Lorenzini M, Potena L, Leone O, Bartolomei I, Pastorelli F, Salvi F, Rapezzi C (2014) Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy. JACC Cardiovasc Imaging 7(5):531\u2013532. https:\/\/doi.org\/10.1016\/j.jcmg.2014.03.004","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"2840_CR24","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s12350-021-02575-0","volume":"28","author":"M Bianco","year":"2021","unstructured":"Bianco M, Parente A, Biol\u00e8 C, Righetti C, Spirito A, Luciano A, Destefanis P, Nangeroni G, Angusti T, Anselmino M, Montagna L (2021) The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol 28(3):825\u2013830. https:\/\/doi.org\/10.1007\/s12350-021-02575-0","journal-title":"J Nucl Cardiol Off Publ Am Soc Nucl Cardiol"},{"issue":"1","key":"2840_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s40119-021-00219-5","volume":"10","author":"MH Rozenbaum","year":"2021","unstructured":"Rozenbaum MH, Large S, Bhambri R, Stewart M, Whelan J, van Doornewaard A, Dasgupta N, Masri A, Nativi-Nicolau J (2021) Impact of delayed diagnosis and misdiagnosis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM): a targeted literature review. Cardiol Therapy 10(1):141\u2013159. https:\/\/doi.org\/10.1007\/s40119-021-00219-5","journal-title":"Cardiol Therapy"},{"issue":"21","key":"2840_CR26","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.jacc.2019.09.056","volume":"74","author":"J Ternacle","year":"2019","unstructured":"Ternacle J, Krapf L, Mohty D, Magne J, Nguyen A, Galat A, Gallet R, Teiger E, C\u00f4t\u00e9 N, Clavel MA, Tournoux F, Pibarot P, Damy T (2019) Aortic stenosis and cardiac amyloidosis: JACC review topic of the week. J Am Coll Cardiol 74(21):2638\u20132651. https:\/\/doi.org\/10.1016\/j.jacc.2019.09.056","journal-title":"J Am Coll Cardiol"},{"key":"2840_CR27","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2147\/CIA.S265103","volume":"15","author":"R Adam","year":"2020","unstructured":"Adam R, Munteanu A, Mititelu R, Onciul S, Deleanu D, Iliescu VA, Popescu BA, Jurcut R (2020) Severe aortic stenosis and ATTRwt amyloidosis: beware in the aging: a case report and review of the literature. Clin Interv Aging 15:1863\u20131872. https:\/\/doi.org\/10.2147\/CIA.S265103","journal-title":"Clin Interv Aging"},{"issue":"3","key":"2840_CR28","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.cjca.2019.11.039","volume":"36","author":"CC Cheung","year":"2020","unstructured":"Cheung CC, Roston TM, Andrade JG, Bennett MT, Davis MK (2020) Arrhythmias in cardiac amyloidosis: challenges in risk stratification and treatment. Can J Cardiol 36(3):416\u2013423. https:\/\/doi.org\/10.1016\/j.cjca.2019.11.039","journal-title":"Can J Cardiol"},{"issue":"3","key":"2840_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.115.018852","volume":"133","author":"LH Connors","year":"2016","unstructured":"Connors LH, Sam F, Skinner M, Salinaro F, Sun F, Ruberg FL, Berk JL, Seldin DC (2016) Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: a prospective. Observat Cohort Study Circul 133(3):282\u2013290. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018852","journal-title":"Observat Cohort Study Circul"},{"issue":"10","key":"2840_CR30","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","volume":"68","author":"M Grogan","year":"2016","unstructured":"Grogan M, Scott CG, Kyle RA, Zeldenrust SR, Gertz MA, Lin G, Klarich KW, Miller WL, Maleszewski JJ, Dispenzieri A (2016) Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. J Am Coll Cardiol 68(10):1014\u20131020. https:\/\/doi.org\/10.1016\/j.jacc.2016.06.033","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2840_CR31","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","volume":"120","author":"L Staerk","year":"2017","unstructured":"Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH (2017) Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res 120(9):1501\u20131517. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.309732","journal-title":"Circ Res"},{"issue":"23","key":"2840_CR32","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/eurheartj\/ehv583","volume":"37","author":"T Damy","year":"2016","unstructured":"Damy T, Costes B, Hag\u00e8ge AA, Donal E, Eicher JC, Slama M, Guellich A, Rappeneau S, Gueffet JP, Logeart D, Plant\u00e9-Bordeneuve V, Bouvaist H, Huttin O, Mulak G, Dubois-Rand\u00e9 JL, Goossens M, Canoui-Poitrine F, Buxbaum JN (2016) Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness. Eur Heart J 37(23):1826\u20131834. https:\/\/doi.org\/10.1093\/eurheartj\/ehv583","journal-title":"Eur Heart J"},{"issue":"1","key":"2840_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jacc.2019.04.054","volume":"74","author":"EL Fosb\u00f8l","year":"2019","unstructured":"Fosb\u00f8l EL, R\u00f8rth R, Leicht BP, Schou M, Maurer MS, Kristensen SL, Kober L, Gustafsson F (2019) Association of carpal tunnel syndrome with amyloidosis, heart failure, and adverse cardiovascular outcomes. J Am Coll Cardiol 74(1):15\u201323. https:\/\/doi.org\/10.1016\/j.jacc.2019.04.054","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"2840_CR34","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","volume":"72","author":"BW Sperry","year":"2018","unstructured":"Sperry BW, Reyes BA, Ikram A, Donnelly JP, Phelan D, Jaber WA, Shapiro D, Evans PJ, Maschke S, Kilpatrick SE, Tan CD, Rodriguez ER, Monteiro C, Tang WHW, Kelly JW, Seitz WH Jr, Hanna M (2018) Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release. J Am Coll Cardiol 72(17):2040\u20132050. https:\/\/doi.org\/10.1016\/j.jacc.2018.07.092","journal-title":"J Am Coll Cardiol"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-023-02840-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-023-02840-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-023-02840-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T09:21:09Z","timestamp":1686216069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-023-02840-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["2840"],"URL":"https:\/\/doi.org\/10.1007\/s10554-023-02840-y","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,1]]},"assertion":[{"value":"10 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}